Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

November 30, 2006

Conditions
Nasal Congestion
Interventions
DRUG

Diphenhydramine hydrochloride

After a ten-hour fast and a one-hour fluid restriction prior to each dosing period, subjects received supervised dosing of their first 25 mg treatment with approximately eight ounces of water. Following a seven-day washout, the comparison treatment was administered according to thye same procedure.

All Listed Sponsors
lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT00662337 - Bioequivalence Between Two Oral Formulations of Diphenhydramine Hydrochloride | Biotech Hunter | Biotech Hunter